title: ClC-3: more than just a volume-sensitive Cl- channel.
abstract: Pulmonary vascular medial hypertrophy due to enhanced pulmonary artery smooth muscle cell (PASMC) proliferation and/or decreased PASMC apoptosis is a primary cause of increased pulmonary vascular resistance and arterial pressure in patients with pulmonary arterial hypertension. While many factors can contribute to this form of vascular remodeling, it is generally agreed upon that altered transmembrane ion flux via ion channels is involved. While much focus has centered on the role of cations and cation channels in controlling PASMC contraction and proliferation, anion efflux via Cl- channels has recently gained interest for its role in SMC proliferation, differentiation, migration, contraction, and angiogenesis. In this issue, Dai et al. report that the putative volume-sensitive ClC-3 channel is upregulated in PASMC from monocrotaline-induced pulmonary hypertensive rats and in inflammatory cytokine-treated canine PASMC. They also provide evidence that ClC-3 upregulation may protect against oxidative stress-induced PASMC necrosis, thereby improving PASMC survival and promoting medial hypertrophy.
authors.affiliation: Department of Medicine, School of Medicine, University of California, 9500 Gilman Drive, San Diego, La Jolla, CA 92093-0725, USA.
authors.forename: Carmelle V
authors.initials: CV
authors.lastname: Remillard
authors.forename: Jason X-J
authors.initials: JX
authors.lastname: Yuan
mesh_terms: D000818:Animals; D049109:Cell Proliferation; D018118:Chloride Channels / Q000502:physiology*; D005786:Gene Expression Regulation / Q000502:physiology; D006984:Hypertrophy / Q000503:physiopathology; D009131:Muscle, Smooth, Vascular / Q000502:physiology*; D011651:Pulmonary Artery / Q000502:physiology*
chemical_list: D018118:Chloride Channels; C115376:ClC-3 channel
references.citation: Bioessays. 1997 Feb;19(2):117-26
references.pmid: 9046241
references.citation: Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9487-92
references.pmid: 10900263
references.citation: Jpn J Pharmacol. 2001 Jul;86(3):310-5
references.pmid: 11488431
references.citation: Prog Cardiovasc Dis. 2002 Sep-Oct;45(2):81-114
references.pmid: 12411972
references.citation: Circ Res. 2002 Nov 15;91(10):E28-32
references.pmid: 12433844
references.citation: Br J Pharmacol. 2005 May;145(1):5-14
references.pmid: 15723096
references.citation: Am J Physiol. 1997 Feb;272(2 Pt 1):C667-74
references.pmid: 9124311
references.citation: Annu Rev Physiol. 1997;59:89-144
references.pmid: 9074758
references.citation: Nature. 1997 Nov 27;390(6658):417-21
references.pmid: 9389484
references.citation: J Physiol. 1998 Mar 15;507 ( Pt 3):729-36
references.pmid: 9508834
references.citation: J Mol Cell Cardiol. 1999 Mar;31(3):657-66
references.pmid: 10198195